Difference between revisions of "John Chisholm"

From Powerbase
Jump to: navigation, search
Line 3: Line 3:
 
In 1991, Chisholm was asked by the UK [[Ministry of Defence]] to organise a number of their research organisations into a single entity, which eventually became the [[Defence Evaluation and Research Agency]] (DERA) - the largest science and technology organisation in the UK. In July 2001, three quarters of DERA was spun off to form a new private company called [[QinetiQ]]. In late 2005 Chisholm became Executive Chairman of QinetiQ, being replaced as CEO by [[Graham Love]]. According to ''[[The Sunday Times]]'' his annual pay was £467,000 in 2004. His £129,000 investment in the company was later worth £23m (a 17,829.5% return on his investment, almost 180 times the initial value of the investment suggesting the company was undervalued and the taxpayer was ripped off).<ref>BBC [http://news.bbc.co.uk/2/hi/business/7108444.stm Qinetiq deal 'cost UK taxpayers'] 22 November 2007</ref> Chisholm made millions when the research division of [[QinetiQ]] was privitised under the stewardship of [[Lewis Moonie]].  American private equity company [[Carlyle Group]] bought the assets for an eightth of their value.  Chisholm managed to turn £129,000 into £22 million when the research arm was floated. Speaking to the Guardian Lord Gillbert, who gave evidence to the [[National Audit Office]] in relation to the matter said:
 
In 1991, Chisholm was asked by the UK [[Ministry of Defence]] to organise a number of their research organisations into a single entity, which eventually became the [[Defence Evaluation and Research Agency]] (DERA) - the largest science and technology organisation in the UK. In July 2001, three quarters of DERA was spun off to form a new private company called [[QinetiQ]]. In late 2005 Chisholm became Executive Chairman of QinetiQ, being replaced as CEO by [[Graham Love]]. According to ''[[The Sunday Times]]'' his annual pay was £467,000 in 2004. His £129,000 investment in the company was later worth £23m (a 17,829.5% return on his investment, almost 180 times the initial value of the investment suggesting the company was undervalued and the taxpayer was ripped off).<ref>BBC [http://news.bbc.co.uk/2/hi/business/7108444.stm Qinetiq deal 'cost UK taxpayers'] 22 November 2007</ref> Chisholm made millions when the research division of [[QinetiQ]] was privitised under the stewardship of [[Lewis Moonie]].  American private equity company [[Carlyle Group]] bought the assets for an eightth of their value.  Chisholm managed to turn £129,000 into £22 million when the research arm was floated. Speaking to the Guardian Lord Gillbert, who gave evidence to the [[National Audit Office]] in relation to the matter said:
  
:"At the time I told the defence secretary ([[George Robertson]]) that this would be a bloody scandel but the treasury under [[Gordon Brown]] insisted on selling a stake in the agency to cut the defence budget...Frankly the money made by by the leading civil servants was obscene.  This is shown by the facts themselves.  They did not contribute anything to the turnaround of the company" <ref> David Hencke, Guardian 21st November 2007, page 4, ''Auditors condemn rushed MoD sale that turned civil servants into multimillionaires'' </ref>         
+
:"At the time I told the defence secretary ([[George Robertson]]) that this would be a bloody scandal but the treasury under [[Gordon Brown]] insisted on selling a stake in the agency to cut the defence budget...Frankly the money made by by the leading civil servants was obscene.  This is shown by the facts themselves.  They did not contribute anything to the turnaround of the company" <ref> David Hencke, Guardian 21st November 2007, page 4, ''Auditors condemn rushed MoD sale that turned civil servants into multimillionaires'' </ref>         
  
 
In 2008, the chairman of the House of Commons [[Public Accounts Committee]] accused Chisholm of "profiteering at the expense of the taxpayer". In response, Chisholm stated that the criticisms were “grossly unfair”, and that "the reshaping of Qinetiq had been the greatest achievement of my working life”. At that time, his stake was worth just over £21m.<ref>http://business.timesonline.co.uk/tol/business/industry_sectors/technology/article5683362.ece Times Online feb 8 2009</ref>  
 
In 2008, the chairman of the House of Commons [[Public Accounts Committee]] accused Chisholm of "profiteering at the expense of the taxpayer". In response, Chisholm stated that the criticisms were “grossly unfair”, and that "the reshaping of Qinetiq had been the greatest achievement of my working life”. At that time, his stake was worth just over £21m.<ref>http://business.timesonline.co.uk/tol/business/industry_sectors/technology/article5683362.ece Times Online feb 8 2009</ref>  

Revision as of 09:41, 6 April 2010

Sir John Chisholm became the Executive Chairman of QinetiQ in 2005, having been at the helm of its predecessor the Defence Evaluation and Research Agency. He became non-executive Chairman of QinetiQ in October 2006. Sir John is a Fellow of the Royal Academy of Engineering, the Royal Aeronautical Society, the Institute of Physics, and is currently a Trustee and President of the Institute of Engineering & Technology (formerly the Institution of Electrical Engineers). He is a frequent speaker on change management, technology and defence science issues. He has been President of the Electrical Engineering Association and was a founder member of the UK Government's Technology Foresight programme. Knighted in 1999, Chisholm was appointed as the Chairman of the Medical Research Council. [1]

In 1991, Chisholm was asked by the UK Ministry of Defence to organise a number of their research organisations into a single entity, which eventually became the Defence Evaluation and Research Agency (DERA) - the largest science and technology organisation in the UK. In July 2001, three quarters of DERA was spun off to form a new private company called QinetiQ. In late 2005 Chisholm became Executive Chairman of QinetiQ, being replaced as CEO by Graham Love. According to The Sunday Times his annual pay was £467,000 in 2004. His £129,000 investment in the company was later worth £23m (a 17,829.5% return on his investment, almost 180 times the initial value of the investment suggesting the company was undervalued and the taxpayer was ripped off).[2] Chisholm made millions when the research division of QinetiQ was privitised under the stewardship of Lewis Moonie. American private equity company Carlyle Group bought the assets for an eightth of their value. Chisholm managed to turn £129,000 into £22 million when the research arm was floated. Speaking to the Guardian Lord Gillbert, who gave evidence to the National Audit Office in relation to the matter said:

"At the time I told the defence secretary (George Robertson) that this would be a bloody scandal but the treasury under Gordon Brown insisted on selling a stake in the agency to cut the defence budget...Frankly the money made by by the leading civil servants was obscene. This is shown by the facts themselves. They did not contribute anything to the turnaround of the company" [3]

In 2008, the chairman of the House of Commons Public Accounts Committee accused Chisholm of "profiteering at the expense of the taxpayer". In response, Chisholm stated that the criticisms were “grossly unfair”, and that "the reshaping of Qinetiq had been the greatest achievement of my working life”. At that time, his stake was worth just over £21m.[4]

Chisholm was a founding member of the British Government's Technology Foresight programme, and has been President of the Electrical Engineering Association. He was President of the Institution of Electrical Engineers (2005-2006) and President of the Institution of Engineering and Technology (2006). He was knighted in 1999.

Appointed Chairman of the Medical Research Council by the Government, a position he took up in October 2006, he succeeded Sir Anthony Cleaver who had been in the post since 1998. Cleaver welcomed Chisholm's appointment stating him as a strong advocate for research. "Sir John's passion in promoting the value of research will be invaluable to the Medical Research Council as we enter a further period of change." [5]


References

  1. Medical Research Council Website News and Events Last accessed November 12th 2007
  2. BBC Qinetiq deal 'cost UK taxpayers' 22 November 2007
  3. David Hencke, Guardian 21st November 2007, page 4, Auditors condemn rushed MoD sale that turned civil servants into multimillionaires
  4. http://business.timesonline.co.uk/tol/business/industry_sectors/technology/article5683362.ece Times Online feb 8 2009
  5. MRC MRC News Release 8 May 2006